Brief: Hanx Biopharmaceuticals (Wuhan) Enters Agreement To Explore AI For Science In Drug Research
21/09/2026 11:40
BRIEF-Hanx Biopharmaceuticals (Wuhan) Enters Agreement To Explore AI For Science In Drug Research Sept 21 (Reuters) - Hanx Biopharmaceuticals (Wuhan) Co Ltd 3378.HK:
AGREEMENT TO EXPLORE AI FOR SCIENCE IN DRUG RESEARCH AND DEVELOPMENT AND MOLECULE DESIGN
TO PROCURE XTALPI SCIENCE PLATFORM SERVICES FOR RESEARCH AND DEVELOPMENT
Further company coverage: 3378.HK
((reuters.briefs@thomsonreuters.com))
Recent news on Hanx Biopharmaceuticals (Wuhan)
See all newsBrief: Hanx Biopharmaceuticals (Wuhan) Enters Agreement To Explore AI For Science In Drug Research
Brief: Hanx Biopharmaceuticals (Wuhan)Enters Agreement To Establish Joint Ai-Driven Drug Discovery Lab
Brief: Hanx Biopharmaceuticals (Wuhan) And Twinedge Bioscience Initiates Research Collaboration
Farmers in biggest cocoa producer are very short of fertilizer, survey says
Brief: Hanx Biopharmaceuticals (Wuhan) Says Xiao Jieyu Re-Designated As Executive Director